立体定向放射外科治疗中高级别动静脉畸形:按补充Spetzler-Martin分级系统分层的结果
该研究对219例Spetzler-Martin(SM)III级或IV-V级脑动静脉畸形(AVM)患者行立体定向放射外科(SRS)治疗,按补充Spetzler-Martin(Supp-SM)分级系统分层。结果显示Supp-SM评分与畸形血管团闭塞(HR 0.94,95%CI 0.82-1.09,p=0.43)或神经功能下降(HR 1.15,95%CI 0.84-1.56,p=0.38)均不相关。作者结论认为Supp-SM分级系统不能预测中高级别AVM的SRS治疗结果。
要点
- Supp-SM评分与SRS后AVM闭塞不相关(HR 0.94,95%CI 0.82-1.09,p=0.43)。
- Supp-SM评分与SRS后神经功能下降不相关(HR 1.15,95%CI 0.84-1.56,p=0.38)。
- 深部位置(HR 0.57,95%CI 0.39-0.82,p=0.003)和AVM体积增大(HR 0.96,95%CI 0.93-0.99,p=0.002)预测未闭塞。
核心结论
- Supp-SM分级系统不能预测中高级别AVM的SRS治疗结果。
- 在Supp-SM分级≥7的「不可手术」AVM占47%的队列中,多数患者SRS后获得闭塞,但神经功能下降风险较高。
研究设计与样本
- 回顾性研究,纳入1990年至2016年接受SRS的219例SM III级(n=154)或SM IV-V级(n=65)AVM患者。
- 计算Supp-SM分级:4分(n=14,6%)、5分(n=36,16%)、6分(n=67,31%)、7分(n=76,35%)、8-9分(n=26,12%)。
- 60例(27%)为深部AVM(基底节、丘脑或脑干);39例(18%)行体积分期SRS;41例(19%)行重复SRS。
- SM III级AVM中位随访69个月,SM IV-V级AVM中位随访113个月。
主要发现
- 163例(74%)在中位38个月后确认AVM闭塞;4年和8年闭塞率分别为59%和76%。
- 31例(14%)出现SRS后神经功能缺损,其中出血7例(3%)、放射损伤24例(11%)。
- 6例(3%)SRS后死亡(出血5例,放射损伤1例);4年和8年神经功能下降或死亡率分别为11%和18%。
- 预测未闭塞的因素为深部位置(HR 0.57,95%CI 0.39-0.82,p=0.003)和AVM体积增大(HR 0.96,95%CI 0.93-0.99,p=0.002)。
- AVM体积增大是唯一与神经功能下降相关的因素(HR 1.05,95%CI 1.02-1.08,p=0.002)。
关键数值与推荐
- Supp-SM评分与闭塞不相关(HR 0.94,95%CI 0.82-1.09,p=0.43)。
- Supp-SM评分与神经功能下降不相关(HR 1.15,95%CI 0.84-1.56,p=0.38)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The supplemented Spetzler-Martin (Supp-SM) grading system was developed to improve the predictive accuracy of surgical risk for patients with brain arteriovenous malformations (AVMs). The aim of this study was to apply the Supp-SM grading system to patients having stereotactic radiosurgery (SRS) for Spetzler-Martin (SM) intermediate- (grade III) or high-grade (grade IV-V) AVMs to enable comparison with published microsurgical series. METHODS: In 219 patients who underwent SRS during the period from 1990 to 2016, the Supp-SM grade was calculated for SM grade III (n = 154) or SM grade IV-V (n = 65) AVMs. The Supp-SM grades in these patients were 4 (n = 14, 6%), 5 (n = 36, 16%), 6 (n = 67, 31%), 7 (n = 76, 35%), and 8-9 (n = 26, 12%). Sixty patients (27%) had deep AVMs (basal ganglia, thalamus, or brainstem). Thirty-nine patients (18%) had volume-staged SRS; 41 patients (19%) underwent repeat SRS. The median follow-up period was 69 months for SM grade III AVMs and 113 months for SM grade IV-V AVMs. RESULTS: AVM obliteration was confirmed in 163 patients (74%) at a median of 38 months after initial SRS. The obliteration rates at 4 and 8 years were 59% and 76%, respectively. Thirty-one patients (14%) had post-SRS deficits from hemorrhage (n = 7, 3%) or radiation injury (n = 24, 11%). Six patients (3%) died after SRS (hemorrhage, n = 5; radiation injury, n = 1). The rates of neurological decline or death at 4 and 8 years were 11% and 18%, respectively. Factors predictive of nonobliteration were deep location (HR 0.57, 95% CI 0.39-0.82, p = 0.003) and increasing AVM volume (HR 0.96, 95% CI 0.93-0.99, p = 0.002). Increasing AVM volume was the only factor associated with neurological decline (HR 1.05, 95% CI 1.02-1.08, p = 0.002). The Supp-SM grading score did not correlate with either obliteration (HR 0.94, 95% CI 0.82-1.09, p = 0.43) or neurological decline (HR 1.15, 95% CI 0.84-1.56, p = 0.38). CONCLUSIONS: The Supp-SM grading system was not predictive of outcomes after SRS of intermediate- or high-grade AVM. In a cohort that included a high percentage (47%) of "inoperable" AVMs according to Supp-SM grade (≥ 7), most patients had obliteration after SRS, although there was a high risk of neurological decline.
引用
- Naylor RM, Graffeo CS, Nesvick CL, et al. Stereotactic radiosurgery for intermediate- and high-grade arteriovenous malformations: outcomes stratified by the supplemented Spetzler-Martin grading system. J Neurosurg. 2022. PMID: 35901695. doi:10.3171/2022.5.JNS22761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。